Tech Company Financing Transactions Funding Round

On 10/12/2023, raised $19.5 million in Seed investment from Andreessen Horowitz, LionBird and NFX.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Proceeds Purpose
The company intends to use the funds to advance development of its proprietary, purpose-built AI LNP platform to deliver RNA and gene therapies to specific extrahepatic tissues in the body.

Company Information

Company Status
Private & Independent
Mailing Address
Tel Aviv, Undisclosed
Email Address
Overview is an AI based drug delivery startup, focusing on gene therapy including DNA and RNA-based therapeutics, and vaccines. is a seed stage biotech company leveraging data, machine learning and high throughput screening to design novel LNPs for targeted extrahepatic delivery of nucleic acid therapeutics and vaccines.
Profile LinkedIn Company Profile
Social Media Company Twitter Account
Company News News
Facebook on Facebook
YouTube on YouTube

Management Team

Email & Social
Chief Executive Officer
Yogev Debbi
  Yogev Debbi LinkedIn Profile  Yogev Debbi Twitter Account  Yogev Debbi News  Yogev Debbi on Facebook
Chief Technical Officer
Roy Nevo
  Roy Nevo LinkedIn Profile  Roy Nevo Twitter Account  Roy Nevo News  Roy Nevo on Facebook



Browse more venture capital transactions:

Prev: 10/12/2023: Natrx venture capital transaction
Next: 10/12/2023: Luna POS venture capital transaction


Share this article


About Database of VC Transactions

We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary